BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 4, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 17, 2012
View Archived Issues
Herbal flavonoid counteracts alcohol intoxication
Read More
Inverseon announces initial indication for INV-102
Read More
Researchers at Sanofi prepare novel endothelial lipase inhibitors
Read More
Sumagen set to start phase I testing of new HIV vaccine
Read More
Merck & Co. presents new GPR119 receptor agonists
Read More
Novel insulin-like growth factor 1 receptor antagonists patented by Novartis
Read More
Novel muscarinic acetylcholine M1 receptor positive allosteric modulators claimed
Read More
Abbott prepares new cannabinoid CB2 receptor ligands
Read More
U.S. team reports new method to stabilize proteins for therapeutic use
Read More
Boehringer Ingelheim and Vitae Pharmaceuticals patent new 11-beta-HSD1 inhibitors
Read More
MediciNova and University of Colorado Boulder collaborate on post-TBI therapy
Read More
Pergamum begins phase II DPK-060 trial in outer ear infections
Read More
Canadian study finds protein kinase inhibitors have potential to reverse resistance to antibiotics
Read More
Omni Bio plans new clinical studies of alpha-1-antitrypsin
Read More
DAPTA analogue reduces neuropathic pain in animal models
Read More
Vernalis and Servier establish new oncology collaboration
Read More
Additional funds support IDRI's work in tuberculosis
Read More
Evotec and Harvard University form new alliance
Read More
Xenetic Biosciences updates status of SymbioTec acquisition and SIIL arrangements
Read More
Idenix launches phase I/II IDX-719 study
Read More
Phase III study of elacytarabine delayed by manufacturing issues
Read More
LoneStar Heart acquires exclusive worldwide license
Read More
Ventana to develop companion diagnostic test for Bayer
Read More
